All data are based on the daily closing price as of February 6, 2026
s
Sunmax Biotechnology
4728.TWO
12.38 USD
0.11
+0.90%
Overview
Last close
12.38 usd
Market cap
674.00M usd
52 week high
16.58 usd
52 week low
7.93 usd
Target price
N/A usd
Valuation
P/E
29.8553
Forward P/E
N/A
Price/Sales
10.6904
Price/Book Value
14.7806
Enterprise Value
656.87M usd
EV/Revenue
18.3803
EV/EBITDA
21.6731
Key financials
Revenue TTM
63.26M usd
Gross Profit TTM
50.02M usd
EBITDA TTM
33.45M usd
Earnings per Share
0.42 usd
Dividend
0.37 usd
Total assets
62.30M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.